Massachusetts Financial Services Co. MA reduced its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 8.0% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 666,201 shares of the company's stock after selling 57,986 shares during the period. Massachusetts Financial Services Co. MA owned 1.34% of Prestige Consumer Healthcare worth $57,273,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also modified their holdings of PBH. Geode Capital Management LLC boosted its holdings in Prestige Consumer Healthcare by 1.7% during the fourth quarter. Geode Capital Management LLC now owns 1,348,745 shares of the company's stock valued at $105,342,000 after acquiring an additional 21,951 shares during the period. Kayne Anderson Rudnick Investment Management LLC acquired a new position in Prestige Consumer Healthcare during the 4th quarter worth $84,932,000. Invesco Ltd. increased its stake in shares of Prestige Consumer Healthcare by 2.4% in the 4th quarter. Invesco Ltd. now owns 1,060,263 shares of the company's stock valued at $82,796,000 after buying an additional 24,392 shares during the period. Congress Asset Management Co. raised its position in shares of Prestige Consumer Healthcare by 9.1% during the 1st quarter. Congress Asset Management Co. now owns 991,580 shares of the company's stock valued at $85,246,000 after acquiring an additional 82,838 shares during the last quarter. Finally, Northern Trust Corp increased its position in shares of Prestige Consumer Healthcare by 10.9% in the 4th quarter. Northern Trust Corp now owns 813,076 shares of the company's stock valued at $63,493,000 after buying an additional 80,055 shares in the last quarter. 99.95% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of equities analysts have recently commented on the stock. Wall Street Zen upgraded shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday, July 5th. Royal Bank Of Canada upgraded shares of Prestige Consumer Healthcare to a "hold" rating in a research report on Thursday, May 8th. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $93.33.
Read Our Latest Research Report on Prestige Consumer Healthcare
Prestige Consumer Healthcare Stock Performance
Prestige Consumer Healthcare stock opened at $75.20 on Friday. The company has a current ratio of 4.20, a quick ratio of 2.82 and a debt-to-equity ratio of 0.55. Prestige Consumer Healthcare Inc. has a 1-year low of $64.94 and a 1-year high of $90.04. The firm has a market capitalization of $3.72 billion, a PE ratio of 17.53, a price-to-earnings-growth ratio of 2.25 and a beta of 0.43. The firm's 50 day simple moving average is $83.16 and its 200 day simple moving average is $82.28.
Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The company reported $1.32 EPS for the quarter, topping the consensus estimate of $1.30 by $0.02. The business had revenue of $296.52 million during the quarter, compared to analyst estimates of $289.36 million. Prestige Consumer Healthcare had a net margin of 18.86% and a return on equity of 12.87%. The company's revenue for the quarter was up 7.0% on a year-over-year basis. During the same period in the prior year, the business earned $1.02 EPS. As a group, analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.
About Prestige Consumer Healthcare
(
Free Report)
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Prestige Consumer Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Prestige Consumer Healthcare wasn't on the list.
While Prestige Consumer Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
